Thiazolides as novel antiviral agents. 1. Inhibition of hepatitis B virus replication
- PMID: 21553812
- PMCID: PMC3124649
- DOI: 10.1021/jm200153p
Thiazolides as novel antiviral agents. 1. Inhibition of hepatitis B virus replication
Abstract
We report the syntheses and activities of a wide range of thiazolides [viz., 2-hydroxyaroyl-N-(thiazol-2-yl)amides] against hepatitis B virus replication, with QSAR analysis of our results. The prototypical thiazolide, nitazoxanide [2-hydroxybenzoyl-N-(5-nitrothiazol-2-yl)amide, NTZ] 1 is a broad spectrum antiinfective agent effective against anaerobic bacteria, viruses, and parasites. By contrast, 2-hydroxybenzoyl-N-(5-chlorothiazol-2-yl)amide 3 is a novel, potent, and selective inhibitor of hepatitis B replication (EC(50) = 0.33 μm) but is inactive against anaerobes. Several 4'- and 5'-substituted thiazolides show good activity against HBV; by contrast, some related salicyloylanilides show a narrower spectrum of activity. The ADME properties of 3 are similar to 1; viz., the O-acetate is an effective prodrug, and the O-aryl glucuronide is a major metabolite. The QSAR study shows a good correlation of observed EC(90) for intracellular virions with thiazolide structural parameters. Finally we discuss the mechanism of action of thiazolides in relation to the present results.
Figures









Similar articles
-
Thiazolides as novel antiviral agents. 2. Inhibition of hepatitis C virus replication.J Med Chem. 2011 Dec 22;54(24):8670-80. doi: 10.1021/jm201264t. Epub 2011 Nov 21. J Med Chem. 2011. PMID: 22059983
-
Nitazoxanide, tizoxanide and other thiazolides are potent inhibitors of hepatitis B virus and hepatitis C virus replication.Antiviral Res. 2008 Jan;77(1):56-63. doi: 10.1016/j.antiviral.2007.08.005. Epub 2007 Sep 4. Antiviral Res. 2008. PMID: 17888524
-
Amidate Prodrugs of Deoxythreosyl Nucleoside Phosphonates as Dual Inhibitors of HIV and HBV Replication.J Med Chem. 2016 Oct 27;59(20):9513-9531. doi: 10.1021/acs.jmedchem.6b01260. Epub 2016 Oct 17. J Med Chem. 2016. PMID: 27748590
-
Thiazolides: a new class of antiviral drugs.Expert Opin Drug Metab Toxicol. 2009 Jun;5(6):667-74. doi: 10.1517/17425250902988487. Expert Opin Drug Metab Toxicol. 2009. PMID: 19442032 Review.
-
Nitazoxanide: a first-in-class broad-spectrum antiviral agent.Antiviral Res. 2014 Oct;110:94-103. doi: 10.1016/j.antiviral.2014.07.014. Epub 2014 Aug 7. Antiviral Res. 2014. PMID: 25108173 Free PMC article. Review.
Cited by
-
Therapeutic potential of salicylamide derivatives for combating viral infections.Med Res Rev. 2023 Jul;43(4):897-931. doi: 10.1002/med.21940. Epub 2023 Mar 10. Med Res Rev. 2023. PMID: 36905090 Free PMC article. Review.
-
N-(5-Nitro-1,3-thia-zol-2-yl)-4-(tri-fluoro-meth-yl)benzamide.Acta Crystallogr Sect E Struct Rep Online. 2013 May 22;69(Pt 6):o943. doi: 10.1107/S1600536813011264. Print 2013 Jun 1. Acta Crystallogr Sect E Struct Rep Online. 2013. PMID: 23795106 Free PMC article.
-
Thiazolides Elicit Anti-Viral Innate Immunity and Reduce HIV Replication.Sci Rep. 2016 Jun 2;6:27148. doi: 10.1038/srep27148. Sci Rep. 2016. PMID: 27250526 Free PMC article.
-
Antiprotozoal Nitazoxanide Derivatives: Synthesis, Bioassays and QSAR Study Combined with Docking for Mechanistic Insight.Curr Comput Aided Drug Des. 2015;11(1):21-31. doi: 10.2174/1573409911666150414145937. Curr Comput Aided Drug Des. 2015. PMID: 25872791 Free PMC article.
-
Tizoxanide Inhibits Inflammation in LPS-Activated RAW264.7 Macrophages via the Suppression of NF-κB and MAPK Activation.Inflammation. 2019 Aug;42(4):1336-1349. doi: 10.1007/s10753-019-00994-3. Inflammation. 2019. PMID: 30937840
References
-
- Chen DS. Hepatitis B vaccination: the key towards elimination and eradication of hepatitis B. J. Hepatol. 2009;50:805–816. - PubMed
-
- Dane DS, Cameron CH, Briggs M. Virus-like particles in serum of patients with Australia-antigen-associated hepatitis. Lancet. 1970:695–698. - PubMed
- Summers J, O’Connell A, Millman I. Genome of hepatitis B virus: restriction enzyme cleavage and structure of DNA extracted from Dane particles. Proc. Nat. Acad. Sci. USA. 1975;72:4597–4601. - PMC - PubMed
-
- Blumberg BS. Australia Antigen and the Biology of Hepatitis B. Science. 1977;197:17–25. - PubMed
-
- Poland GA. Evaluating existing recommendations for hepatitis A and B vaccination. Am. J. Med. 2005;118(10A):16S–20S. - PubMed
- Ni YH, Chang MH, Huang LM, Chen HL, Hsu HY, Chiu TY, Tsai KS, Chen DS. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination. Ann. Intern. Med. 2001;135:796–800. - PubMed
-
- Kohlstaedt LA, Wang J, Friedman JM, Rice PA, Steitz TA. Crystal structure at 3.5Å resolution of HIV reverse transcriptase complexed with an inhibitor. Science. 1992;256:1783–1790. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources